Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 38,107 | 34,753 | 33,862 | 29,452 | 25,339 |
| Operating Income | -38,107 | -34,753 | -33,862 | -29,452 | -25,339 |
| Other Income | 6,610 | 6,228 | 3,719 | 3,739 | 3,870 |
| Pre-tax Income | -31,497 | -28,525 | -30,143 | -25,713 | -21,469 |
| Net Income Continuous | -31,497 | -28,525 | -30,143 | -25,713 | -21,469 |
| Net Income | $-31,497 | $-28,525 | $-30,143 | $-25,713 | $-21,469 |
| EPS Basic Total Ops | -0.34 | -0.33 | -0.46 | -0.41 | -0.34 |
| EPS Basic Continuous Ops | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 |
| EPS Diluted Total Ops | -0.34 | -0.33 | -0.46 | -0.41 | -0.34 |
| EPS Diluted Continuous Ops | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.33 | -0.47 | N/A | N/A |
| EBITDA(a) | $-41,126 | $-37,378 | $-35,501 | $-31,330 | $-27,773 |